Shandong Wit Dyne Health Co.,Ltd.

SZSE:000915 Stock Report

Market Cap: CN¥6.7b

Shandong Wit Dyne HealthLtd Future Growth

Future criteria checks 3/6

Shandong Wit Dyne HealthLtd is forecast to grow earnings and revenue by 16.5% and 14.5% per annum respectively. EPS is expected to grow by 16.6% per annum. Return on equity is forecast to be 20.7% in 3 years.

Key information

16.5%

Earnings growth rate

16.6%

EPS growth rate

Pharmaceuticals earnings growth19.3%
Revenue growth rate14.5%
Future return on equity20.7%
Analyst coverage

Low

Last updated29 Oct 2024

Recent future growth updates

No updates

Recent updates

Is There An Opportunity With Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) 38% Undervaluation?

Oct 27
Is There An Opportunity With Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) 38% Undervaluation?

There's No Escaping Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) Muted Earnings

Sep 14
There's No Escaping Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) Muted Earnings

Shandong Wit Dyne HealthLtd (SZSE:000915) Is Increasing Its Dividend To CN¥2.00

May 12
Shandong Wit Dyne HealthLtd (SZSE:000915) Is Increasing Its Dividend To CN¥2.00

Shandong Wit Dyne HealthLtd's (SZSE:000915) Earnings Offer More Than Meets The Eye

Apr 24
Shandong Wit Dyne HealthLtd's (SZSE:000915) Earnings Offer More Than Meets The Eye

Earnings and Revenue Growth Forecasts

SZSE:000915 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,043739N/A1,4192
12/31/20252,707653N/A1,2652
12/31/20242,399572N/A1,1342
9/30/20242,143490733777N/A
6/30/20242,4855959501,000N/A
3/31/20242,4955901,0191,069N/A
12/31/20232,4845851,1241,175N/A
9/30/20232,2415251,1581,209N/A
6/30/20232,2695441,1081,184N/A
3/31/20232,2975351,1691,256N/A
12/31/20222,3415271,1071,196N/A
9/30/20222,2735249961,093N/A
6/30/20222,2414569081,023N/A
3/31/20222,143427785895N/A
1/1/20222,027380636756N/A
9/30/20212,027382693799N/A
6/30/20212,000385676753N/A
3/31/20211,986350692777N/A
12/31/20201,821291634736N/A
9/30/20201,852277564692N/A
6/30/20201,821250501643N/A
3/31/20201,804230257415N/A
12/31/20191,80020471244N/A
9/30/20191,56214139223N/A
6/30/20191,54113717200N/A
3/31/20191,39080214371N/A
1/1/20191,526130407539N/A
9/30/20181,699170376571N/A
6/30/20181,698178N/A596N/A
3/31/20181,775231N/A509N/A
12/31/20171,767243N/A426N/A
9/30/20171,794255N/A410N/A
6/30/20171,694239N/A422N/A
3/31/20171,662238N/A450N/A
12/31/20161,545198N/A501N/A
9/30/20161,529229N/A474N/A
6/30/20161,415195N/A345N/A
3/31/20161,312156N/A341N/A
12/31/20151,233152N/A290N/A
9/30/20151,246162N/A227N/A
6/30/20151,310206N/A287N/A
3/31/20151,317211N/A236N/A
12/31/20141,374217N/A272N/A
9/30/20141,266178N/A255N/A
6/30/20141,198149N/A230N/A
3/31/20141,173165N/A222N/A
12/31/20131,095153N/A216N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000915's forecast earnings growth (16.5% per year) is above the savings rate (2.9%).

Earnings vs Market: 000915's earnings (16.5% per year) are forecast to grow slower than the CN market (25.8% per year).

High Growth Earnings: 000915's earnings are forecast to grow, but not significantly.

Revenue vs Market: 000915's revenue (14.5% per year) is forecast to grow faster than the CN market (14% per year).

High Growth Revenue: 000915's revenue (14.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 000915's Return on Equity is forecast to be high in 3 years time (20.7%)


Discover growth companies